Quantification of brain endocannabinoid levels: Methods, interpretations and pitfalls

British Journal of Pharmacology

Volumn 160, Issue 3, 2010, Pages 423-442

  Buczynski, Matthew W ^a   Parsons, Loren H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

2 arachidonoylglycerol; Anandamide; Brain; Extracellular; FAAH; GC MS; LC MS; MAGL; Microdialysis; Quantitative analysis

Indexed keywords

BETA CYCLODEXTRIN; CANNABINOID DERIVATIVE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE; JZL 184; JZL 195; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE A; PHOSPHOLIPASE C; PHOSPHOLIPASE D; UNCLASSIFIED DRUG; URB 602; CANNABINOID RECEPTOR AFFECTING AGENT;

ANIMAL TISSUE; AUTOPSY; BIODEGRADATION; BIOSYNTHESIS; BRAIN; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DIALYSATE; DRUG POTENCY; EXTRACTION; FLOW RATE; GAS CHROMATOGRAPHY; IMPLANTATION; IN VIVO STUDY; LIPID EXTRACTION; LIQUID CHROMATOGRAPHY; MEMBRANE COMPONENT; MICRODIALYSIS; MOLECULAR PROBE; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; RAT; REVIEW; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TISSUE LEVEL; ANIMAL; BRAIN LEVEL; CHEMICAL ANALYSIS; DEVICES; HUMAN; METABOLISM; PROCEDURES;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CANNABINOID RECEPTOR MODULATORS; CHEMISTRY TECHNIQUES, ANALYTICAL; ENDOCANNABINOIDS; HUMANS; MICRODIALYSIS;

EID: 77952666794     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00787.x     Document Type: Review

References (179)

1. Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K, Stanimirovic D (2005). Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J Neurochem 92 : 1477 1486.
2. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK et al. (2009). Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16 : 411 420.
3. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 209.
4. Alger BE (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68 : 247 286.
5. Alvarez-Jaimes L, Polis I, Parsons LH (2009a). Regional influence of CB1 receptor signaling on ethanol self-administration by rats. The Open Neuropsychopharmacology 2 : 77 85.
6. Alvarez-Jaimes L, Stouffer DG, Parsons LH (2009b). Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. J Neurochem 111 : 37 48.
7. Arai Y, Fukushima T, Shirao M, Yang X, Imai K (2000). Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. Biomed Chromatogr 14 : 118 124.
8. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C et al. (2008). Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781 : 200 212.
9. Bacci A, Huguenard JR, Prince DA (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 : 312 316.
10. Bari M, Battista N, Fezza F, Finazzi-Agro A, Maccarrone M (2005). Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280 : 12212 12220.
11. Baseski HM, Watson CJ, Cellar NA, Shackman JG, Kennedy RT (2005). Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely-moving rats. J Mass Spectrom 40 : 146 153.
12. Bazinet RP, Lee H-J, Felder CC, Porter AC, Rapoport SI, Rosenberger TA (2005). Rapid high-energy microwave fixation is required to determine the ananadamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem Res 30 : 597 601.
13. Benveniste H, Diemer NH (1987). Cellular reactions to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathol 74 : 234 238.
14. Benveniste H, Drejer J, Schousboe A, Diemer NH (1987). Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J Neurochem 49 : 729 734.
15. Bequet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C et al. (2007). CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. Eur J Neurosci 26 : 3458 3464.
16. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ et al. (1999). Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256 : 377 380.
17. Bisogno T, Melck D, Bobrov M, Gretskaya NM, Bezuglov VV, De Petrocellis L et al. (2000). N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 351 (Pt 3 817 824.
18. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A et al. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163 : 463 468.
19. Bisogno T, Cascio MG, Saha B, Mahadevan A, Urbani P, Minassi A et al. (2006). Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochim Biophys Acta 1761 : 205 212.
20. Blankman JL, Simon GM, Cravatt BF (2007). A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14 : 1347 1356.
21. Bligh EG, Dyer WJ (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 : 911 917.
22. Bojesen IN, Hansen HS (2003). Binding of anandamide to bovine serum albumin. J Lipid Res 44 : 1790 1794.
23. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V et al. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31 : 2652 2659.
24. Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A et al. (2007). Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62 : 1103 1110.
25. Bradshaw HB, Rimmerman N, Krey JF, Walker JM (2006). Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. Am J Physiol Regul Integr Comp Physiol 291 : R349 R358.
26. Cabranes A, Venderova K, de Lago E, Fezza F, Sanchez A, Mestre L et al. (2005). Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol Dis 20 : 207 217.
27. Cadas H, Gaillet S, Beltramo M, Venance L, Piomelli D (1996). Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci 16 : 3934 3942.
28. Caille S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH (2007). Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27 : 3695 3702.
29. Cenedella RJ, Galli C, Paoletti R (1975). Brain free fatty levels in rats sacrificed by decapitation versus focused microwave irradiation. Lipids 10 : 290 293.
30. Clapp-Lilly KL, Roberts RC, Duffy LK, Irons KP, Hu Y, Drew KL (1999). An ultrastructural analysis of tissue surrounding a microdialysis probe. J Neurosci Methods 90 : 129 142.
31. Collias JC, Manuelidis EE (1957). Histopathological changes produced by implanted electrodes in cat brains; comparison with histopathological changes in human and experimental puncture wounds. J Neurosurg 14 : 302 328.
32. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 : 83 87.
33. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR et al. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98 : 9371 9376.
34. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 : 1946 1949.
35. Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL et al. (2005). Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 569 : 751 760.
36. Di Marzo V, Maccarrone M (2008). FAAH and anandamide: is 2-AG really the odd one out? Trends Pharmacol Sci 29 : 229 233.
37. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC et al. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 : 686 691.
38. Di Marzo V, De Petrocellis L, Sugiura T, Waku K (1996). Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem Biophys Res Commun 227 : 281 288.
39. Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM (2000). Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14 : 1432 1438.
40. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM et al. (1992). Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem 58 : 931 940.
41. Farias SE, Basselin M, Chang L, Heidenreich KA, Rapoport SI, Murphy RC (2008). Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res 49 : 1990 2000.
42. Faure J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B et al. (2006). Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 31 : 642 648.
43. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G et al. (2005). Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313 : 352 358.
44. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J et al. (1996). Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393 : 231 235.
45. Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A (2003). Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18 : 1607 1614.
46. Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A et al. (2007). Regulation of brain anandamide by acute administration of ethanol. Biochem J 404 : 97 104.
47. Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 : 497 509.
48. Fride E (2008). Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development. J Neuroendocrinol 20 (Suppl. 1 75 81.
49. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M (2003). Lipid raft-associated protein sorting in exosomes. Blood 102 : 4336 4344.
50. Gerdeman GL, Lovinger DM (2003). Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140 : 781 789.
51. Giuffrida A, Piomelli D (1998). Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422 : 373 376.
52. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999). Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2 : 358 363.
53. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M et al. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102 : 18620 18625.
54. Golovko MY, Murphy EJ (2008). An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J Lipid Res 49 : 893 902.
55. Gonzalez S, Bisogno T, Wenger T, Manzanares J, Milone A, Berrendero F et al. (2000). Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem Biophys Res Commun 270 : 260 266.
56. Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002a). Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954 : 73 81.
57. Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA (2002b). Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 66 : 77 84.
58. Gonzalez S, Fernandez-Ruiz J, Di Marzo V, Hernandez M, Arevalo C, Nicanor C et al. (2004a). Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend 74 : 159 170.
59. Gonzalez S, Valenti M, de Miguel R, Fezza F, Fernandez-Ruiz J, Di Marzo V et al. (2004b). Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Br J Pharmacol 143 : 455 464.
60. Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S (1998). Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422 : 69 73.
61. Grabb MC, Sciotti VM, Gidday JM, Cohen SA, van Wylen DG (1998). Neurochemical and morphological responses to acutely and chronically implanted brain microdialysis probes. J Neurosci Methods 82 : 25 34.
62. Guindon J, Hohmann AG (2009). The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8 : 403 421.
63. Haller J, Varga B, Ledent C, Barna I, Freund TF (2004). Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19 : 1906 1912.
64. Hanus L, Gopher A, Almog S, Mechoulam R (1993). Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J Med Chem 36 : 3032 3034.
65. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE et al. (2001). 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98 : 3662 3665.
66. Hardison S, Weintraub ST, Giuffrida A (2006). Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat 81 : 106 112.
67. Hascup ER, af Bjerken S, Hascup KN, Pomerleau F, Huettl P, Stromberg I et al. (2009). Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex. Brain Res 1291 : 12 20.
68. Heifets BD, Castillo PE (2009). Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 71 : 283 306.
69. Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, Hakansson L, Nordberg A et al. (1990). Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neurosci Lett 110 : 172 179.
70. Herrera-Marschitz M, Meana JJ, O'Connor WT, Goiny M, Reid MS, Ungerstedt U (1992). Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids 2 : 157 179.
71. Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV et al. (1996). On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem 66 : 1726 1735.
72. Hoffman AF, Lupica CR (2001). Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 85 : 72 83.
73. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R et al. (2005). An endocannabinoid mechanism for stress-induced analgesia. Nature 435 : 1108 1112.
74. Hoover HS, Blankman JL, Niessen S, Cravatt BF (2008). Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Lett 18 : 5838 5841.
75. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F et al. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99 : 8400 8405.
76. Kaczocha M, Glaser ST, Deutsch DG (2009). Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 106 : 6375 6380.
77. Karbarz MJ, Luo L, Chang L, Tham CS, Palmer JA, Wilson SJ et al. (2009). Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase. Anesth Analg 108 : 316 329.
78. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9 : 76 81.
79. Keefe KA, Zigmond MJ, Abercrombie ED (1992). Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47 : 325 332.
80. Kempe K, Hsu FF, Bohrer A, Turk J (1996). Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J Biol Chem 271 : 17287 17295.
81. Khramov AN, Stenken JA (1999). Enhanced microdialysis recovery of some tricyclic antidepressants and structurally related drugs by cyclodextrin- mediated transport. Analyst 124 : 1027 1033.
82. King AR, Duranti A, Tontini A, Rivara S, Rosengarth A, Clapper JR et al. (2007). URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol 14 : 1357 1365.
83. Kingsley PJ, Marnett LJ (2007). LC-MS-MS analysis of neutral eicosanoids. Methods Enzymol 433 : 91 112.
84. Kingsley PJ, Marnett LJ (2009). Analysis of endocannabinoids, their congeners and COX-2 metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 877 : 2746 2754.
85. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136 : 550 557.
86. Klein U, Gimpl G, Fahrenholz F (1995). Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34 : 13784 13793.
87. de Lago E, Petrosino S, Valenti M, Morera E, Ortega-Gutierrez S, Fernandez-Ruiz J et al. (2005). Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem Pharmacol 70 : 446 452.
88. Lambert DM, Fowler CJ (2005). The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem 48 : 5059 5087.
89. Lanckmans K, Van Eeckhaut A, Sarre S, Smolders I, Michotte Y (2006). Capillary and nano-liquid chromatography-tandem mass spectrometry for the quantification of small molecules in microdialysis samples: comparison with microbore dimensions. J Chromatogr A 1131 : 166 175.
90. Lastres-Becker I, Fezza F, Cebeira M, Bisogno T, Ramos JA, Milone A et al. (2001). Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport 12 : 2125 2129.
91. Legido-Quigley C, Smith NW, Mallet D (2002). Quantification of the sensitivity increase of a micro-high-performance liquid chromatography- electrospray ionization mass spectrometry system with decreasing column diameter. J Chromatogr A 976 : 11 18.
92. Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL et al. (2004a). Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311 : 441 448.
93. Lichtman AH, Shelton CC, Advani T, Cravatt BF (2004b). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109 : 319 327.
94. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE et al. (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5 : 37 44.
95. Lopez-Moreno JA, Gonzalez-Cuevas G, Moreno G, Navarro M (2008). The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict Biol 13 : 160 187.
96. Lutz B (2009). Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9 : 46 52.
97. Maccarrone M, Attina M, Cartoni A, Bari M, Finazzi-Agro A (2001). Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. J Neurochem 76 : 594 601.
98. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A et al. (2008). Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11 : 152 159.
99. Maccarrone M, De Chiara V, Gasperi V, Viscomi MT, Rossi S, Oddi S et al. (2009). Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. J Neurochem 109 : 371 381.
100. Maidment NL, Evans CJ (1991). Measurement of extracellular neuropeptides in the brain: microdialysis linked to solid-phase radioimmunoassays with sub-femtomole limits of detection. In : Robinson TE, Justice JB, Jr. (eds). Microdialysis in the Neurosciences. Elsevier
101. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M et al. (2006). Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J Pharmacol Exp Ther 316 : 969 982.
102. Makriyannis A, Guo J, Tian X (2005a). Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer. Life Sci 77 : 1605 1611.
103. Makriyannis A, Tian X, Guo J (2005b). How lipophilic cannabinergic ligands reach their receptor sites. Prostaglandins Other Lipid Mediat 77 : 210 218.
104. Malinen H, Lehtonen M, Hyytia P (2009). Modulation of brain endocannabinoid levels by voluntary alcohol consumption in alcohol-preferring AA rats. Alcohol Clin Exp Res 33 : 1711 1720.
105. Marinelli S, Pacioni S, Bisogno T, Di Marzo V, Prince DA, Huguenard JR et al. (2008). The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci 28 : 13532 13541.
106. Marinelli S, Pacioni S, Cannich A, Marsicano G, Bacci A (2009). Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci 12 : 1488 1490.
107. Marion J, Wolfe LS (1979). Origin of the arachidonic acid released post-mortem in rat forebrain. Biochim Biophys Acta 574 : 25 32.
108. Matias I, Vergoni AV, Petrosino S, Ottani A, Pocai A, Bertolini A et al. (2008). Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins. Neuropharmacology 54 : 206 212.
109. Maysinger D, Herrera-Marschitz M, Carlsson A, Garofalo L, Cuello AC, Ungerstedt U (1988). Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1. Brain Res 461 : 355 360.
110. Mechoulam R, Shohami E (2007). Endocannabinoids and traumatic brain injury. Mol Neurobiol 36 : 68 74.
111. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50 : 83 90.
112. Mechoulam R, Panikashvili D, Shohami E (2002). Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 8 : 58 61.
113. Moreira FA, Kaiser N, Monory K, Lutz B (2008). Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54 : 141 150.
114. Muccioli GG, Stella N (2008). An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. Anal Biochem 373 : 220 228.
115. Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH (2007). Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 192 : 61 70.
116. Natarajan V, Schmid PC, Schmid HH (1986). N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim Biophys Acta 878 : 32 41.
117. Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M (2005). Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium. Cell Calcium 38 : 369 374.
118. Ohvo H, Slotte JP (1996). Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry 35 : 8018 8024.
119. Oosterkamp AJ, Gelpi E, Abian J (1998). Quantitative peptide bioanalysis using column-switching nano liquid chromatography/mass spectrometry. J Mass Spectrom 33 : 976 983.
120. Opitz CA, Rimmerman N, Zhang Y, Mead LE, Yoder MC, Ingram DA et al. (2007). Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett 581 : 4927 4931.
121. Orio L, Edwards S, George O, Parsons LH, Koob GF (2009). A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J Neurosci 29 : 4846 4857.
122. Osborne PG, O'Connor WT, Drew KL, Ungerstedt U (1990). An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J Neurosci Methods 34 : 99 105.
123. Osei-Hyiaman D, Depetrillo M, Harvey-White J, Bannon AW, Cravatt BF, Kuhar MJ et al. (2005). Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 81 : 273 282.
124. Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C et al. (2006). Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur J Neurosci 24 : 2011 2020.
125. Palkovits M, Harvey-White J, Liu J, Kovacs ZS, Bobest M, Lovas G et al. (2008). Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience 152 : 1032 1039.
126. Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P (2009). Endocannabinoids and immune regulation. Pharmacol Res 60 : 85 92.
127. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R et al. (2001). An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413 : 527 531.
128. Parolaro D, Rubino T (2008). The role of the endogenous cannabinoid system in drug addiction. Drug News Perspect 21 : 149 157.
129. Patel S, Rademacher DJ, Hillard CJ (2003). Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306 : 880 888.
130. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004). Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145 : 5431 5438.
131. Patel S, Carrier EJ, Ho W-SV, Rademacher DJ, Cunningham S, Reddy DS et al. (2005). The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hyrdolase activity. J Lipid Res 46 : 342 349.
132. Pertwee R, Griffin G, Hanus L, Mechoulam R (1994). Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia. Eur J Pharmacol 259 : 115 120.
133. Petrosino S, Palazzo E, de Novellis V, Bisogno T, Rossi F, Maione S et al. (2007). Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 52 : 415 422.
134. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J et al. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301 : 1020 1024.
135. Re G, Barbero R, Miolo A, Di Marzo V (2007). Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet J 173 : 21 30.
136. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA (2007). Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal Biochem 360 : 216 226.
137. Rimmerman N, Hughes HV, Bradshaw HB, Pazos MX, Mackie K, Prieto AL et al. (2008). Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. Br J Pharmacol 153 : 380 389.
138. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K (1999). Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10 : 961 974.
139. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J et al. (2001). An anorexic lipid mediator regulated by feeding. Nature 414 : 209 212.
140. Roy S, Rieutord A, Zhou JY, Baillet A, Prognon P, Chaminade P (2003). The benefit of the retrofitting of a conventional LC system to micro LC: a practical evaluation in the field of bioanalysis with fluorimetric detection. Biomed Chromatogr 17 : 297 305.
141. Rubio M, McHugh D, Fernandez-Ruiz J, Bradshaw H, Walker JM (2007). Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci Lett 421 : 270 274.
142. Schabitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S et al. (2002). Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33 : 2112 2114.
143. Schmid PC, Krebsbach RJ, Perry SR, Dettmer TM, Maasson JL, Schmid HH (1995). Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett 375 : 117 120.
144. Schmid PC, Schwartz KD, Smith CN, Krebsbach RJ, Berdyshev EV, Schmid HH (2000). A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. Chem Phys Lipids 104 : 185 191.
145. Schneiderman E, Stalcup AM (2000). Cyclodextrins: a versatile tool in separation science. J Chromatogr B Biomed Sci Appl 745 : 83 102.
146. Schoffelmeer AN, Hogenboom F, Wardeh G, De Vries TJ (2006). Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology 51 : 773 781.
147. Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A (2009). Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Int J Neuropsychopharmacol 1 14.
148. Solinas M, Goldberg SR, Piomelli D (2008). The endocannabinoid system in brain reward processes. Br J Pharmacol 154 : 369 383.
149. Soria-Gomez E, Matias I, Rueda-Orozco PE, Cisneros M, Petrosino S, Navarro L et al. (2007). Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol 151 : 1109 1116.
150. Sperlagh B, Windisch K, Ando RD, Sylvester Vizi E (2009). Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Neurochem Int 54 : 452 457.
151. Stella N (2009). Endocannabinoid signaling in microglial cells. Neuropharmacology 56 (Suppl. 1 244 253.
152. Stella N, Piomelli D (2001). Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425 : 189 196.
153. Stella N, Schweitzer P, Piomelli D (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 : 773 778.
154. Stensas S, Stensas L (1976). The reaction of the cerebral cortex to chronically implanted plastic needles. Acta Neuropathol 35 : 187 203.
155. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215 : 89 97.
156. Sugiura T, Yoshinaga N, Waku K (2001). Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci Lett 297 : 175 178.
157. Tan B, Yu YW, Monn MF, Hughes HV, O'Dell DK, Walker JM (2009). Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue. J Chromatogr B Analyt Technol Biomed Life Sci 877 : 2890 2894.
158. Timmerman W, Westerink BH (1997). Brain microdialysis of GABA and glutamate: what does it signify? Synapse 27 : 242 261.
159. Tossman U, Ungerstedt U (1986). Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 128 : 9 14. (Pubitemid 16023701)
160. Uekama K, Hirayama F, Irie T (1998). Cyclodextrin Drug Carrier Systems. Chem Rev 98 : 2045 2076.
161. Valenti M, Vigano D, Casico MG, Rubino T, Steardo L, Parolaro D et al. (2004). Differential diurnal variations of anandamide and 2-arachidonoyl- glycerol levels in rat brain. Cell Mol Life Sci 61 : 945 950.
162. Vigano D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V et al. (2003). Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28 : 1160 1167.
163. Villanueva A, Yilmaz SM, Millington WR, Cutrera RA, Stouffer DG, Parsons LH et al. (2009). Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area. Shock 32 : 614 620.
164. Viveros MP, de Fonseca FR, Bermudez-Silva FJ, McPartland JM (2008). Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications. Endocr Metab Immune Disord Drug Targets 8 : 220 230.
165. Wages SA, Church WH, Justice JB, Jr. (1986). Sampling considerations for on-line microbore liquid chromatography of brain dialysate. Anal Chem 58 : 1649 1656.
166. Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC (1999). Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96 : 12198 12203.
167. Walter L, Dinh T, Stella N (2004). ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24 : 8068 8074.
168. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A et al. (2000). Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 470 : 151 155.
169. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M et al. (2001). Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem 294 : 73 82.
170. Westerink BH, Hofsteede HM, Damsma G, de Vries JB (1988). The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 337 : 373 378.
171. Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P et al. (2007). Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem 79 : 5582 5593.
172. Wilson RI, Nicoll RA (2002). Endocannabinoid signaling in the brain. Science 296 : 678 682.
173. Witting A, Walter L, Wacker J, Moller T, Stella N (2004). P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101 : 3214 3219.
174. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A et al. (1991). Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33 : 227 236.
175. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J et al. (2003). Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278 : 10963 10972.
176. Yagen B, Burstein S (2000). Novel and sensitive method for the detection of anandamide by the use of its dansyl derivative. J Chromatogr B Biomed Sci Appl 740 : 93 99.
177. Yang HY, Karoum F, Felder C, Badger H, Wang TC, Markey SP (1999). GC/MS analysis of anandamide and quantification of N- arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J Neurochem 72 : 1959 1968.
178. You ZB, Herrera-Marschitz M, Brodin E, Meana JJ, Morino P, Hokfelt T et al. (1994a). On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J Neurochem 62 : 76 85.
179. You ZB, Nylander I, Herrera-Marschitz M, O'Connor WT, Goiny M, Terenius L (1994b). The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis - I. Effects of K(+)-depolarization, lesions and peptidase inhibition. Neuroscience 63 : 415 425.